The use of two inhaled beta agonists for the treatment of COPD: a summary of European data.
Holten
K
K
Lung Medicine Department, Vest-Agder Sentralsykehus, Kristiansand, Norway.
Lulling
J
J
Schaaning
J
J
Vander Straeten
M
M
Verstraeten
J M
JM
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use*; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008875:Middle Aged; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; C009118:pirbuterol; D000420:Albuterol